The ASX has a couple of new notches in its belt, ticking off new intraday and closing highs after the RBA cut interest rates ...

The ASX inched higher at lunch as traders wait on an RBA cut and names like JB Hi-Fi, Life360 and Star made the morning’s ...

Despite its well-publicised problems, the FDA is a happy place for ASX biotechs seeking drug or device approvals.

The Aussie bourse has had a strong start to the week with the S&P/ASX 200 finishing Monday up 0.43% to hit a fresh 100-day high.

Round 22 done and dusted and the panel talks it through. Every game, every highlight, every boundary throw-in. Okay, maybe not ...

GRL’s updated resource of 470,000oz gold and 21Moz silver along with zinc, copper and lead confirms Lewis Ponds as large, high-grade deposit.

AnteoTech (ASX:ADO) is breaking into the South Korean market with a distribution agreement with Kangshin Industrial Co.

Biotechs increasingly are taking out loan advances, backed by their eventual refunds under the federal Research & Development ...

QMines’ drilling has extended and confirmed thecontinuity of high-grade mineralisation at the Sulphide City deposit in ...

ASX-listed Nanosonics, Optiscan, and Clever Culture Systems are transforming healthcare efficiency through innovative medtech ...

Three in four Australians want tech giants banned from using local content to train AI systems without permission or ...

The ASX continued its upward momentum in the first hour of trade this morning, climbing after setting a new record high yesterday.